Leerink Partners Remains Bullish on Cynosure (CYNO) Following SculpSure Debut
Tweet Send to a Friend
Leerink Partners reiterated an Outperform rating and $45.00 price target on Cynosure (NASDAQ: CYNO) following its SculpSure debut. This will ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
